Table Va.
Means ± SD of the stabilometric parameters (and the relative percentage of pathological patients for whom the instrument supplies standardised values). The Table also shows the statistically significant differences resulting from comparison of the pre- and post-rehabilitation data in Group A and Group B separately.
| Group A | ||||||||
|---|---|---|---|---|---|---|---|---|
| Xmin | Xmax | Xmed | SDX | Ymin | Ymax | Ymed | SDY | |
| Pre-OE | 22/90 (24.44%) -13.72 ± 8.07 |
14/90 (15.56%) 7.16 ± 9.70 |
11/90 (12.22%) -3.22 ± 7.49 |
0.41 ± 0.17 | 16/90 (17.78%) -57.19 ± 18.62 |
9/90 (10%) -33.16 ± 18.16* |
17/90 (18.89%) -45.70 ± 17.73 |
0.50 ± 0.24 |
| Post-OE | 16/90 (17.78%) -13.05 ± 8.34 |
8/90 (8.89%) 7.01 ± 7.60 |
6/90 (6.67%) -2.92 ± 5.59 |
0.40 ± 0.20 | 18/90 (20%) -61.39 ± 16.72 |
14/90 (15.56%) -38.81 ± 16.65* |
13/90 (14.44%) -50.42 ± 15.21 |
0.45 ± 0.21 |
| Pre-CE | 30/90 (33.33%) -19.42 ± 11.48 |
11/90 (12.22%) 13.53 ± 12.23 |
15/90 (16.67%) -3.07 ± 8.96 |
0.64 ± 0.29 | 28/90 (31.11%) -65.61 ± 21.77 |
16/90 (17.78%) -27.95 ± 20.45 |
19/90 (21.11%) -47.30 ± 16.44 |
0.77 ± 0.38§ |
| Post-CE | 25/90 (27.78%) -16.76 ± 12.64 |
13/90 (14.44%) 11.95 ± 11.46 |
10/90 (11.11%) -2.85 ± 7.39 |
0.57 ± 0.29 | 23/90 (25.56%) -64.33 ± 17.34 |
9/90 (10%) -32.31 ± 14.18 |
18/90 (20%) -47.08 ± 16.95 |
0.64 ± 0.24§ |
| Pre-CER | 35/90 (38.89%)§ -22.89 ± 13.08§ |
19/90 (21.11%) 17.69 ± 15.59 |
11/90 (12.22%) -2.20 ± 8.45 |
0.76 ± 0.35§ | 73/90 (81.11%) -71.49 ± 20.73* |
34/90 (37.78%)§ -23.23 ± 21.74 |
26/90 (28.89%) -46.55 ± 18.01 |
0.92 ± 0.38§ |
| Post-CER | 19/90 (21.11%)§ -17.93 ± 10.13§ |
12/90 (13.33%) 13.88 ± 11.24 |
6/90 (6.67%) -2.12 ± 7.18 |
0.60 ± 0.28§ | 64/90 (71.11%) -64.90 ± 18.68* |
17/90 (18.89%)§ -27.15 ± 16 |
20/90 (22.22%) -46.36 ± 15.91 |
0.75 ± 0.33§ |
| Group B | ||||||||
| Pre-OE | 8/20 (40%) -15.18 ± 9.60 |
8/20 (40%) 4.13 ± 11.67 |
5/20 (25%) -5.14 ± 9.24 |
0.39 ± 0.17 | 8/20 (40%) -62.63 ± 24.85 |
6/20 (30%) -37.82 ± 22.58 |
7/20 (35%) -44.33 ± 25.60 |
0.56 ± 0.25 |
| Post-OE | 3/20 (15%) -14.89 ± 5.85 |
3/20 (15%) 3.12 ± 8.06 |
3/20 (15%) -6.04 ± 6.95 |
0.34 ± 0.11 | 5/20 (25%) -60.78 ± 22.24 |
3/20 (15%) -39.06 ± 21.38 |
5/20 (25%) -47.35 ± 22.88 |
0.43 ± 0.20 |
| Pre-CE | 9/20 (45%) -20.77 ± 10.63 |
7/20 (35%) 13.64 ± 16.18 |
7/20 (35%) -4.01 ± 8.72 |
0.65 ± 0.30 | 9/20 (45%) -66.64 ± 26.48 |
6/20 (30%) -27.47 ± 24.04 |
7/20 (35%) -45.48 ± 23.65 |
0.74 ± 0.35* |
| Post-CE | 6/20 (30%) -22.44 ± 11.19 |
2/20 (10%) 6.53 ± 11.16 |
7/20 (35%) -6.40 ± 9.14 |
0.52 ± 0.26 | 6/20 (30%) -64.55 ± 25.26 |
5/20 (25%) -34.59 ± 21.04 |
5/20 (25%) -48.58 ± 22.08 |
0.54 ± 0.25* |
| Pre-CER | 12/20 (60%)§ -23.31 ± 12.79 |
8/20 (40%) 18.36 ± 17.48 |
4/20 (20%) -1.01 ± 10.83 |
0.74 ± 0.23 | 17/20 (85%) -67.52 ± 28.19 |
10/20 (50%) -23.60 ± 28.07 |
6/20 (30%) -46.41 ± 27.12 |
0.95 ± 0.44 |
| Post-CER | 4/20 (20%)§ -21.65 ± 10.20 |
6/20 (30%) 15.25 ± 11.86 |
2/20 (10%) -3.43 ± 7.75 |
0.67 ± 0.26 | 14/20 (70%) -69.90 ± 21.03 |
7/20 (35%) -28.81 ± 23.48 |
5/20 (25%) -49.13 ± 21.20 |
0.85 ± 0.40 |
§
p < 0.01;
#
p = 0.01;
*
p = 0.03.